ABBOTT Architect 25-OH Vitamin D assay Singapore - English - HSA (Health Sciences Authority)

abbott architect 25-oh vitamin d assay

abbott laboratories (singapore ) private limited - immunology - the architect 25-oh vitamin d assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of 25-hydroxyvitamin d (25-oh vitamin d) in human serum and plasma. the architect 25-oh vitamin d assay is to be used as an aid in the assessment of vitamin d sufficiency.

Abbott Architect Anti-HBe Assay (LN 6C34) Singapore - English - HSA (Health Sciences Authority)

abbott architect anti-hbe assay (ln 6c34)

abbott laboratories (singapore ) private limited - immunology - the architect anti-hbe assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of antibody to hepatitis b e antigen in human serum and plasma and is indicated for use as an aid in the diagnosis and monitoring of hepatitis b viral infection. use with abbott architect i2000 system and abbott architect i2000sr system.

Abbott Architect Cyclosporine Assay Singapore - English - HSA (Health Sciences Authority)

abbott architect cyclosporine assay

abbott laboratories (singapore ) private limited - clinical toxicology - the architect cyclosporine assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of cyclosporine in human whole blood on the architect isystem. the architect cyclosporine assay is used as an aid in the management of heart, liver and kidney transplant patients receiving cyclosporine therapy.

Abbott Architect HBeAg Assay (LN 6C32) Singapore - English - HSA (Health Sciences Authority)

abbott architect hbeag assay (ln 6c32)

abbott laboratories (singapore ) private limited - immunology - the architect hbeag assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of hepatitis b e antigen in human serum and plasma and is indicated for use as an aid in the diagnosis and monitoring of hepatitis b viral infection. use with abbott architect i2000 system and abbott architect i2000sr system. the architect hbeag assay can also be used for the quantitative determination of hbeag. refer to architect hbeag quantitative calibrators package insert (7p24-01) for instructions and further information.

Abbott Architect HBsAg Confirmatory V.1 Assay (LN 9C94) Singapore - English - HSA (Health Sciences Authority)

abbott architect hbsag confirmatory v.1 assay (ln 9c94)

abbott laboratories (singapore ) private limited - immunology - the architect hbsag confirmatory v.1 assay is a chemiluminescent microparticle immunoassay (cmia) for the confirmation of the presence of hepatitis b surface antigen (hbsag) in human serum and plasma by means of specific antibody neutralization. use with abbott architect i2000 system and abbott architect i2000sr system.

Abbott ARCHITECT HBsAG Qualitative II Assay and ARCHITECT HBsAg Qualitative II Confirmatory Assay (2G22 and 2G23). Singapore - English - HSA (Health Sciences Authority)

abbott architect hbsag qualitative ii assay and architect hbsag qualitative ii confirmatory assay (2g22 and 2g23).

abbott laboratories (singapore ) private limited - microbiology - the architect hbsag qualitative ii assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of hepatitis b surface antigen (hbsag) in human serum and plasma including speciments collected post-mortem (non-heart-beating). the architect hbsag qualitative ii assay is intended to be used as an aid in the diagnosis of hbv infection and as a screening test for donated blood and plasma to prevent transmission of hbv to recipients of blood, blood components, cells, tissues and organs. the architect hbsag qualitative ii confirmatory assay is a chemiluminescent microparticle immunoassay (cmia) for the confirmation of the presence of hepatitis b surface antigen (hbsag) in human serum and plasma including specimens collected post-mortem (non-heart-beating) by means of specific antibody neutralization. it is intended to be used for the confirmation of samples found to be repeatedly reactive by architect hbsag qualitative ii.

Abbott Architect iDigoxin Assay Singapore - English - HSA (Health Sciences Authority)

abbott architect idigoxin assay

abbott laboratories (singapore ) private limited - immunology - the architect idigoxin assay is an in vitro chemiluminescent microparticle immunoassay (cmia) for the quantitative measurement of digoxin in human serum or plasma on the architect i system with stat protocol capability. the measurements obtained are used to aid in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to help ensure appropriate therapy.

Abbott ARCHITECT iValproic Acid Assay (1P35) Singapore - English - HSA (Health Sciences Authority)

abbott architect ivalproic acid assay (1p35)

abbott laboratories (singapore ) private limited - clinical chemistry - it is an in vitro chemiluminescent microparticle immunoassay (cmia) for the quantitative measurement of valproic acid, an anticonvulsant drug, in human serum or plasma on the architect i system with stat protocol capability. the measurements obtained are used in monitoring levels of valproic acid to help ensure appropriate therapy.

Abbott ARCHITECT LH Assay (LN 6C25 and 7G94) Singapore - English - HSA (Health Sciences Authority)

abbott architect lh assay (ln 6c25 and 7g94)

abbott laboratories (singapore ) private limited - immunology - the architect lh assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of human luteinizing hormone (lh) in human serum and plasma.

Abbott ARCHITECT Methotrexate Assay Singapore - English - HSA (Health Sciences Authority)

abbott architect methotrexate assay

abbott laboratories (singapore ) private limited - clinical chemistry - the architect methotrexate assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of methotrexate in human serum and plasma on the architect i system with stat protocol capability. the measurements obtained are used in monitoring levels of methotrexate to ensure appropriate therapy